
MRNA vs BNTX
$MRNA vs $BNTX head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
MRNA vs BNTX: the quick read
- ·MRNA is the larger company by market cap ($61.50B vs $24.13B).
- ·MRNA has been more active on our scanner (337 vs 61 alerts in 30 days).
- ·BNTX has the smaller float (109.8M vs 354.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) vs Biological Products, (No Diagnostic Substances)), so they answer to different catalysts and a move in one says little about the other.
- ·MRNA draws far more of our scanner's attention, 337 unusual-volume alerts in 30 days against 61, so it is the more actively traded of the two by some distance.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing MRNA and BNTX on TheDesperateTrader.
- Is MRNA or BNTX the better stock?
- "Better" depends on your goal, and these two are not alike. MRNA is the larger company by market cap ($61.50B vs $24.13B). MRNA has been more active on our scanner (337 vs 61 alerts in 30 days). BNTX has the smaller float (109.8M vs 354.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between MRNA and BNTX?
- The differences that matter: they are not in the same business - MRNA is biological products, (no diagnostic substances) and BNTX is biological products, (no diagnostic substances); they are similar in size ($61.50B vs $24.13B); they trade at very different share prices ($153.87 vs $97.00); MRNA sits at 85% of its 52-week range against 39% for BNTX; our scanner flagged MRNA 337 times in the last 30 days against 61 for BNTX. Everything above is measured from the latest completed session and SEC filings.
- Which of MRNA and BNTX is more active right now?
- Right now MRNA is at about 0.8x its normal volume and BNTX is at about 0.8x, so MRNA is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading MRNA or BNTX? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore MRNA and BNTX comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.